![](/img/cover-not-exists.png)
386TiPRIbociclib plus goserelin with hormonal therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with HR+, HER2– inoperable locally advanced or metastatic breast cancer: RIGHT choice study
El Saghir, N, Malwinder, S, Azim, H, Eralp, Y, Im, S-A, Yap, Y S, Delgar Alfaro, T, Gao, M, Lu, Y-SVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.081
Date:
October, 2019
File:
PDF, 97 KB
2019